Also trades as: 0I3Q.L (LSE) · $vol 0M
CORT NASDAQ
Corcept Therapeutics Incorporated
1W: -22.3%
1M: -24.9%
3M: -7.5%
YTD: +128.1%
1Y: +19.4%
3Y: +211.2%
5Y: +359.6%
$87.59
+0.47 (+0.53%)
After Hours: $86.07 (-1.52, -1.74%)
Weekly Expected Move ±11.6%
$66
$76
$86
$96
$106
Credit Risk of going bust: lower than 85% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Corcept Therapeutics Incorporated would be worth roughly what it owes.
Total debt $9.4M against a stock market value of $9.42B.
Distance to default 11.18 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $5.7M (short-term plus half of long-term), stock volatility 64.9%; Altman Z'' 8.76. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down more than 99.9%), Corcept Therapeutics Incorporated would be worth roughly what it owes.
Total debt $9.4M against a stock market value of $9.42B.
Distance to default 11.18 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $5.7M (short-term plus half of long-term), stock volatility 64.9%; Altman Z'' 8.76. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-09-22
Earliest Filing
2024-04-17
Latest Filing
partner: 1
supplier: 1
Counterparties (Filed by CORT)
2 relationshipsCompanies named in CORT's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-23 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-07-29 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-06-17 | Other Events; Exhibits | View | |
| 2026-06-03 | Other Events | View | |
| 2026-05-28 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-04-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-25 | Other Events; Exhibits | View | |
| 2026-02-24 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-02-19 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-22 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-31 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Regulation FD Disclosure | View | |
| 2025-10-14 | Termination of Material Definitive Agreement; Financial Statements and Exhibits | View | |
| 2025-10-06 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-09-10 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-31 | Results of Operations and Financial Condition; Regulation FD Disclosure | View | |
| 2025-07-14 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-16 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-05-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-31 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR